Anavex Life Sciences Corp (AVXL)
Stock-Based Compensation
-$16.77M
Quarterly · Period ending: · USD
AVXL Stock-Based Compensation
Latest reported-$16.77Mperiod ending
Latest reported-$16.77Mperiod ending
AVXL Quarterly Stock-Based Comp ($0.00 → -$16.77M)
Quarterly stock-based compensation
High-resolution chart · PNG
AVXL stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| -16,770,000 | |
| 0 | |
| 1,107,000 | |
| 3,721,000 | |
| 4,324,000 | |
| 1,449,000 | |
| 2,055,000 | |
| 2,013,000 | |
| 2,487,000 | |
| 2,652,000 | |
| 2,286,000 | |
| 3,186,647 | |
| 3,866,000 | |
| 3,970,000 | |
| 5,347,000 | |
| 6,042,398 | |
| 3,988,614 | |
| 4,439,459 | |
| 3,908,771 | |
| 3,152,008 | |
| 2,293,925 | |
| 1,846,156 | |
| 939,314 | |
| 660,600 | |
| 1,251,129 | |
| 1,700,753 | |
| 1,264,424 | |
| 1,236,530 | |
| 1,234,204 | |
| 1,893,152 | |
| 2,066,987 | |
| 1,491,592 | |
| 1,677,731 | |
| 1,225,696 | |
| 1,121,985 | |
| 1,117,694 | |
| 1,159,716 | |
| 968,893 | |
| 889,267 | |
| 3,785,300 | |
| 228,257 | |
| 222,690 | |
| 826,020 | |
| 1,368,522 | |
| 233,913 | |
| 16,182 | |
| 15,362 | |
| 628,336 | |
| 9,589 | |
| 0 | |
| 0 | |
| 1,002,500 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 98,800 | |
| 80,144 | |
| 123,264 | |
| 257,747 | |
| 159,186 | |
| 668,479 | |
| 187,750 | |
| 145,917 | |
| 227,115 | |
| 265,304 | |
| 131,719 | |
| 256,546 | |
| 201,847 | |
| 153,327 | |
| 200,616 | |
| 0 | |
| 0 | |
| 0 | |
| 248,668 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |